This work highlights the eternal conflict between health for all and the imperative of profitability of intellectual property linked to patents on medicines in the pharmaceutical industry. Health for all is difficult to reconcile with the need for patent profitability. Obtaining a patent for a drug is a long and costly procedure for laboratories...